Compare Abeona Therapeutics Inc (ABEO) vs iShares MSCI ACWI ETF (ACWI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs iShares MSCI ACWI ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while iShares MSCI ACWI ETF trades at $161.9. Which is the better fit depends on your goals.
| ABEO | ACWI | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | — |
52-Week High | $7.45 | $161.44 |
52-Week Low | $4.17 | $132.04 |
Enterprise Value | $276.10M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About iShares MSCI ACWI ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →
